Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A study to evaluate the safety, immunogenicity and efficacy of GlaxoSmithKline Biologicals’ candidate malaria vaccine RTS,S/AS02A, administered intramuscularly according to a 0, 1 and 2 month vaccination schedule in toddlers and children aged 1 to 4 years in a malaria-endemic region of Mozambique.
SB257049
257049/026
NCT00197041
Malaria
Phase 2
 
A follow up study 104297 was conducted. The analysis-ready data from this study is provided in combined datasets with the analysis-ready data from 104297. An annotated case report form is not available for this study. A blank case report form will be provided
July 2014

Powered by ideaPoint, Inc.